SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001072613-19-000106
Filing Date
2019-02-14
Accepted
2019-02-14 15:10:37
Documents
1
Group Members
ARCH VENTURE PARTNERS VIII, L.P.ARCH VENTURE PARTNERS VIII, LLCCLINTON BYBEEKEITH CRANDELLROBERT NELSEN

Document Format Files

Seq Description Document Type Size
1 ARCH VENTURE FUND VIII, L.P. - KURA ONCOLOGY, INC. -- SCHEDULE 13G/A(#3) archviii-kura_13g18289.htm SC 13G/A 94207
  Complete submission text file 0001072613-19-000106.txt   95980
Mailing Address 3033 SCIENCE PARK ROAD, SUITE 220 SAN DIEGO CA 92121
Business Address 3033 SCIENCE PARK ROAD, SUITE 220 SAN DIEGO CA 92121 (858) 500-8800
Kura Oncology, Inc. (Subject) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-83933 | Film No.: 19605156
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8755 W. HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631
Business Address 8755 W. HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631 776-380-6600
ARCH Venture Fund VIII, L.P. (Filed by) CIK: 0001605598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A